Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $499.55 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $91.45 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $90.19 | 4 | $0 (2024) |
| Lilly USA, LLC | $57.04 | 4 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $55.36 | 3 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $52.30 | 4 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $43.42 | 2 | $0 (2024) |
| PFIZER INC. | $36.51 | 1 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $30.19 | 2 | $0 (2021) |
| Novo Nordisk Inc | $22.14 | 1 | $0 (2024) |
| Radius Health, Inc. | $20.95 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $72.76 | 4 | Novo Nordisk Inc ($22.14) |
| 2023 | $44.60 | 2 | Otsuka America Pharmaceutical, Inc. ($24.54) |
| 2022 | $42.39 | 1 | AstraZeneca Pharmaceuticals LP ($42.39) |
| 2021 | $98.29 | 6 | Biohaven Pharmaceuticals, Inc. ($55.36) |
| 2020 | $39.93 | 3 | AstraZeneca Pharmaceuticals LP ($16.73) |
| 2019 | $27.41 | 2 | Janssen Pharmaceuticals, Inc ($27.41) |
| 2018 | $72.34 | 3 | PFIZER INC. ($36.51) |
| 2017 | $101.83 | 2 | Novartis Pharmaceuticals Corporation ($91.45) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: PSYCHIATRY | ||||||
| 03/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Diabetes | ||||||
| 03/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Respiratory | ||||||
| 02/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Diabetes | ||||||
| 09/14/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: NEUROLOGY | ||||||
| 04/13/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Diabetes | ||||||
| 04/04/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $42.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/27/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: PRIMARY CARE | ||||||
| 10/20/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: PRIMARY CARE | ||||||
| 10/06/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Gastroenterology | ||||||
| 09/15/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Gastroenterology | ||||||
| 07/26/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: PRIMARY CARE | ||||||
| 06/16/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/30/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/02/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: Diabetes | ||||||
| 07/08/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/06/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $36.51 | General |
| Category: DERMATOLOGY | ||||||
| 05/16/2018 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Endocrinology | ||||||
| 01/26/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/27/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $91.45 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/16/2017 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 40 | 61 | $7,723 | $3,963 |
| 2022 | 4 | 79 | 128 | $15,191 | $7,956 |
| 2021 | 4 | 80 | 163 | $18,646 | $10,749 |
| 2020 | 4 | 124 | 224 | $24,032 | $14,657 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $3,480 | $1,992 | 57.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 31 | $2,480 | $1,877 | 75.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 12 | 15 | $1,763 | $93.45 | 5.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 55 | $4,400 | $3,058 | 69.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 20 | $4,640 | $2,859 | 61.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 18 | 22 | $2,508 | $1,867 | 74.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 24 | 31 | $3,643 | $172.63 | 4.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 20 | 88 | $7,040 | $4,934 | 70.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 20 | 25 | $5,800 | $3,952 | 68.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 17 | 20 | $2,280 | $1,668 | 73.1% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 23 | 30 | $3,526 | $195.01 | 5.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 30 | 109 | $8,720 | $6,207 | 71.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 31 | 35 | $8,120 | $5,369 | 66.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 29 | 33 | $3,762 | $2,778 | 73.8% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 34 | 47 | $3,430 | $302.53 | 8.8% |
About Dr. William Prater, M.D
Dr. William Prater, M.D is a Family Medicine healthcare provider based in Breckenridge, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700956539.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Prater, M.D has received a total of $499.55 in payments from pharmaceutical and medical device companies, with $72.76 received in 2024. These payments were reported across 23 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($499.55).
As a Medicare-enrolled provider, Prater has provided services to 323 Medicare beneficiaries, totaling 576 services with total Medicare billing of $37,325. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Breckenridge, TX
- Active Since 11/09/2006
- Last Updated 10/11/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1700956539
Products in Payments
- ENTRESTO (Drug) $91.45
- FARXIGA (Drug) $74.00
- NURTEC ODT (Drug) $55.36
- XARELTO (Drug) $52.30
- EUCRISA (Drug) $36.51
- XIFAXAN (Drug) $30.19
- NUEDEXTA (Drug) $24.54
- Ozempic (Drug) $22.14
- Tymlos (Biological) $20.95
- TRULICITY (Drug) $20.06
- REXULTI (Drug) $18.88
- BREZTRI (Drug) $16.19
- MOUNJARO (Drug) $15.55
- BASAGLAR (Drug) $11.05
- JARDIANCE (Drug) $10.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Breckenridge
Kelli Windsor, Do, DO
Family Medicine — Payments: $708.07
Susan Badidi, Md, MD
Family Medicine — Payments: $250.70
Dr. Julie Mckenzie, D.o, D.O
Family Medicine — Payments: $127.43
Kaitlyn Welch
Family Medicine — Payments: $32.40
Nirmal Patel, M.d, M.D
Family Medicine — Payments: $22.05
Randall Nations, M.d, M.D
Family Medicine